TET2 and myelodysplastic syndrome: In MDS patients, downregulation of TET2 and reduction of 5hmC levels are commonly detected irrespective of TET2 mutations, while TET3 is upregulated, this being inversely correlated with TET2 expression, likely due to a feedback mechanism.